Expression of fibroblast growth factor (FGF) 2 and its receptor FGFR1 is upregulated and plays as an escape mechanism for cell survival of afatinib-resistant cancer cells, compensating the loss of EGFR-driven signaling pathway. This evidence concerns the gene EGFR and cancer.